MicroRNA-384 regulates both amyloid precursor protein and β-secretase expression and is a potential biomarker for Alzheimer's disease

International Journal of Molecular Medicine

Volumn 34, Issue 1, 2014, Pages 160-166

  Liu, Chen Geng ^a   Wang, Jin Ling ^a   Li, Lei ^a   Wang, Pei Chang ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Alzheimer's disease; Amyloid precursor protein; MicroRNA; site amyloid precursor protein cleaving enzyme

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; BETA SECRETASE; BETA SECRETASE 1; BIOLOGICAL MARKER; MICRORNA; MICRORNA 384; OLIGONUCLEOTIDE; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); ASPARTIC PROTEINASE; BACE1 PROTEIN, HUMAN; BACE1 PROTEIN, MOUSE; PEPTIDE FRAGMENT; SECRETASE; SMALL INTERFERING RNA;

3' UNTRANSLATED REGION; ADULT; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASSAY; BINDING SITE; BIOINFORMATICS; CEREBROSPINAL FLUID; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HIPPOCAMPUS; HUMAN; LUCIFERASE ASSAY; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; AGED; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; CASE CONTROL STUDY; CELL LINE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

3' UNTRANSLATED REGIONS; AGED; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; ASPARTIC ACID ENDOPEPTIDASES; BINDING SITES; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CELL LINE; FEMALE; GENE EXPRESSION REGULATION; HIPPOCAMPUS; HUMANS; MALE; MICE; MICE, TRANSGENIC; MICRORNAS; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; PEPTIDE FRAGMENTS; RNA, SMALL INTERFERING; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION;

EID: 84902650526     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2014.1780     Document Type: Article

References (20)

1. Weiner MW: Dementia in 2012: further insights into Alzheimer disease pathogenesis. Nat Rev Neurol 2: 65-66, 2013.
2. Singer O, Marr RA, Rockenstein E, et al: Targeting BACE1 with siRNAs ameliorates Alzheimer disease neuropathology in a transgenic model. Nat Neurosci 8: 1343-1349, 2005. (Pubitemid 41630422)
3. Tan L, Yu JT, Hu N and Tan L: Non-coding RNAs in Alzheimer's disease. Mol Neurobiol 47: 382-393, 2013.
4. Junn E and Mouradian MM: MicroRNAs in neurodegenerative diseases and their therapeutic potential. Pharmacol Ther 133: 142-150, 2012.
5. Schonrock N, Matamales M, Ittner LM and Götz J: MicroRNA networks surrounding APP and amyloid-β metabolism - implications for Alzheimer's disease. Exp Neurol 235: 447-454, 2012.
6. Boissonneault V, Plante I, Rivest S and Provost P: MicroRNA-298 and microRNA-328 regulate expression of mouse beta-amyloid precursor protein-converting enzyme 1. J Biol Chem 284: 1971-1981, 2009.
7. Faghihi MA, Modarresi F, Khalil AM, et al: Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase. Nat Med 14: 723-730, 2008.
8. Blennow K, Hampel H, Weiner M and Zetterberg H: Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nat Rev Neurol 6: 131-144, 2010.
9. Zetterberg H, Andreasson U, Hansson O, et al: Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer disease. Arch Neurol 65: 1102-1107 2008.
10. Schonrock N, Ke YD, Humphreys D, et al: Neuronal microRNA deregulation in response to Alzheimer's disease amyloid-beta. PLoS One 5: e11070, 2010.
11. Patel N, Hoang D, Miller N, et al: MicroRNAs can regulate human APP levels. Mol Neurodegener 3: 10, 2008.
12. Wei PC, Tsai CH, Chiu PS and Lai SC: Matrix metalloproteinase-12 leads to elastin degradation in BALB/c mice with eosinophilic meningitis caused by Angiostrongylus cantonensis. Int J Parasitol 41: 1175-1183, 2011.
13. Schonrock N, Humphreys DT, Preiss T and Götz J: Target gene repression mediated by miRNAs miR-181c and miR-9 both of which are down-regulated by amyloid-β. J Mol Neurosci 46: 324-335, 2012.
14. Lindner DJ, Wu Y, Haney R, et al: Thrombospondin-1 expression in melanoma is blocked by methylation and targeted reversal by 5-Aza-deoxycytidine suppresses angiogenesis. Matrix Biol 32: 123-132, 2013.
15. 2+ -ATPase and carbonic anhydrase iv in H9C2 cells. Clin Exp Pharmacol Physiol 34: 998-1004, 2007.
16. Giedraitis V, Sundelöf J, Irizarry MC, et al: The normal equi ?librium between CSF and plasma amyloid beta levels is disrupted in Alzheimer's disease. Neurosci Lett 427: 127-131, 2007. (Pubitemid 47633799)
17. Dassow H and Aigner A: MicroRNAs (miRNAs) in colorectal cancer: from aberrant expression towards therapy. Curr Pharm Des 19: 1242-1252, 2013.
18. Zhang Y, Liu D, Chen X, et al: Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol Cell 39: 133-144, 2010.
19. van Leuven F: Single and multiple transgenic mice as models for Alzheimer's disease. Prog Neurobiol 61: 305-312, 2000.
20. Ma R, Jiang T and Kang X: Circulating microRNAs in cancer: origin, function and application. J Exp Clin Cancer Res 31: 38, 2012.